Aprecia Pharmaceuticals Co — Form D

Aprecia Pharmaceuticals Co of LANGHORNE, PA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-28. The offering totals $84.0M, of which $79.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (34)

Showing 25 of 34 people.

NameRoleLocation
E Thomas AringtonDirectorMason, OH
James Thomas EvansDirectorCincinnati, OH
Lawrence Thomas GlassmannDirectorBlue Ash, OH
Jonathan Thomas LeffDirectorNew York, NY
Etienne Thomas PeroldDirectorPennington, NJ
David Thomas FurnissExecutive OfficerMason, OH
Michael Thomas RolhfsExecutive OfficerBlue Ash, OH
Donald Thomas WetherholdExecutive OfficerBlue Ash, OH
Robert Thomas WillifordExecutive OfficerBlue Ash, OH
Michael KingExecutive OfficerROAD TOWN, TORTOLA, D8
Lawrence Thomas GlassmannExecutive OfficerBlue Ash, OH
E Thomas AringtonExecutive OfficerMason, OH
Michael Thomas RohlfsExecutive OfficerWest Chester, OH
DAVID A FURNISSExecutive OfficerCINCINNATI, OH
ROBERT A WILLIFORDExecutive OfficerCINCINNATI, OH
MICHAEL A ROHLFSExecutive OfficerWEST CHESTER, OH
Etienne A PeroldDirectorPennington, NJ
Etienne A PeroldExecutive OfficerPennington, NJ
DONALD A WETHERHOLDExecutive OfficerLOVELAND, OH
Glenn S VraniakExecutive OfficerManalapan, NJ
Michael S KingExecutive OfficerPrinceton, NJ
Donald C MonkhouseExecutive OfficerRadnor, PA
Don S WetherholdExecutive OfficerLoveland, OH
Michael C KingExecutive OfficerPrinceton, NJ
Lawrence C GlassmannDirectorCincinnati, OH

Other filings by this issuer (11)

FiledFormOfferingSold
2015-08-31D$52.0M$38.8M
2013-12-10D/A$36.3M$14.9M
2013-12-09D$36.2M$14.9M
2012-11-19D$8.6M$4.0M
2011-11-04D$25.7M$25.7M
2010-12-20D/A$4.9M$3.9M
2010-11-08D/A$455K$455K
2010-10-18D$105K$105K
2010-01-25D/A$5.5M$5.5M
2009-12-24D$2.5M$2.5M
2009-05-29D$500K$500K

More